Liver pathology in Wilson's disease: From copper overload to cirrhosis

J Inorg Biochem. 2019 Apr:193:106-111. doi: 10.1016/j.jinorgbio.2019.01.008. Epub 2019 Jan 15.

Abstract

Wilson's disease (WD) is a genetic metabolic disease strictly associated with liver cirrhosis. In this review, the genetic bases of the disease are discussed, with emphasis on the role of ATP7B (the Wilson disease protein) dysfunction as a determinant factor of systemic copper overload. Regarding the different multiple mutations described in WD patients, the peculiarity of Sardinian population is highlighted, Sardinians carrying a rare deletion in the promoter (5' UTR) of the WD gene. The role of epigenetic changes in the clinical presentation and evolution of liver disease in WD patients is also discussed, nutrition probably representing a relevantly risk factor in WD patients. The role of transmission electron microscopy in the diagnosis of WD-related liver disease is underlined. Mitochondrial changes, increased peroxisomes fat droplets, lipolysosomes and intranuclear glycogen inclusions are reported as the most frequent ultrastructural changes in the liver of WD carriers. The role of histochemical stains for copper is analyzed, and the Timm's method is suggested as the most sensitive one for revealing hepatic copper overload in all stage of WD. The marked variability of the histological liver changes occurring in WD is underlined simple steatosis may represent the only pathological changes, frequently associated with glycogenated nuclei. Mallory-Denk bodies lipogranulomas alcoholic and non-alcoholic fatty liver disease ending with bridging fibrosis and cirrhosis. Finally, the reversal of fibrosis as a possible therapeutic objective in WD is discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Copper / metabolism*
  • Copper-Transporting ATPases / genetics
  • Copper-Transporting ATPases / metabolism
  • Epigenesis, Genetic
  • Hepatolenticular Degeneration / drug therapy
  • Hepatolenticular Degeneration / pathology*
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis / drug therapy
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mutation
  • Penicillamine / therapeutic use

Substances

  • Copper
  • ATP7B protein, human
  • Copper-Transporting ATPases
  • Penicillamine